View in EDS

Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.

Saved in:
Bibliographic Details
Title: Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
Authors: Larrayoz M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Garcia-Barchino MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Celay J; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Etxebeste A; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Jimenez M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Perez C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Ordoñez R; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Cobaleda C; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Botta C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy., Fresquet V; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Roa S; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Goicoechea I; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Maia C; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Lasaga M; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Chesi M; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA., Bergsagel PL; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA., Larrayoz MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Calasanz MJ; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., Campos-Sanchez E; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Martinez-Cano J; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain., Panizo C; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Rodriguez-Otero P; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Vicent S; Program in Solid Tumors, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain., Roncador G; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain., Gonzalez P; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain., Takahashi S; Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan., Katz SG; Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Walensky LD; Department of Pediatric Oncology and Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA., Ruppert SM; Oncology Biomarker Development, Genentech, South San Francisco, CA, USA., Lasater EA; Department of Translational Oncology, Genentech, South San Francisco, CA, USA., Amann M; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland., Lozano T; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Llopiz D; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Sarobe P; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Lasarte JJ; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain., Planell N; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain., Gomez-Cabrero D; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain.; Biological and Environmental Sciences & Engineering Division, King Abdullah University of Science & Technology, Thuwal, Kingdom of Saudi Arabia., Kudryashova O; BostonGene, Waltham, MA, USA., Kurilovich A; BostonGene, Waltham, MA, USA., Revuelta MV; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Cerchietti L; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA., Agirre X; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain., San Miguel J; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Paiva B; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Prosper F; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain., Martinez-Climent JA; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain. jamcliment@unav.es.
Source: Nature medicine [Nat Med] 2023 Mar; Vol. 29 (3), pp. 632-645. Date of Electronic Publication: 2023 Mar 16.
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
Journal Info: Publisher: Nature Publishing Company Country of Publication: United States NLM ID: 9502015 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1546-170X (Electronic) Linking ISSN: 10788956 NLM ISO Abbreviation: Nat Med Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 36928817
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Larrayoz+M%22">Larrayoz M</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Garcia-Barchino+MJ%22">Garcia-Barchino MJ</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Celay+J%22">Celay J</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Etxebeste+A%22">Etxebeste A</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Jimenez+M%22">Jimenez M</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Perez+C%22">Perez C</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Ordoñez+R%22">Ordoñez R</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Cobaleda+C%22">Cobaleda C</searchLink>; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Botta+C%22">Botta C</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Health Promotion, Mother and Child Care, Internal Medicine and Medical Specialties, University of Palermo, Palermo, Italy.<br /><searchLink fieldCode="AU" term="%22Fresquet+V%22">Fresquet V</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Roa+S%22">Roa S</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Goicoechea+I%22">Goicoechea I</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Maia+C%22">Maia C</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lasaga+M%22">Lasaga M</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Chesi+M%22">Chesi M</searchLink>; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Bergsagel+PL%22">Bergsagel PL</searchLink>; Department of Medicine, Mayo Clinic Arizona, Scottsdale, AZ, USA.<br /><searchLink fieldCode="AU" term="%22Larrayoz+MJ%22">Larrayoz MJ</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Calasanz+MJ%22">Calasanz MJ</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Campos-Sanchez+E%22">Campos-Sanchez E</searchLink>; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Cano+J%22">Martinez-Cano J</searchLink>; Immune System Development and Function Unit, Centro de Biologia Molecular Severo Ochoa, Consejo Superior de Investigaciones Cientificas/Universidad Autonoma, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Panizo+C%22">Panizo C</searchLink>; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Rodriguez-Otero+P%22">Rodriguez-Otero P</searchLink>; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Vicent+S%22">Vicent S</searchLink>; Program in Solid Tumors, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Roncador+G%22">Roncador G</searchLink>; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Gonzalez+P%22">Gonzalez P</searchLink>; Monoclonal Antibodies Unit, Biotechnology Program, Spanish National Cancer Research Centre CNIO, Madrid, Spain.<br /><searchLink fieldCode="AU" term="%22Takahashi+S%22">Takahashi S</searchLink>; Department of Anatomy and Embryology, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.<br /><searchLink fieldCode="AU" term="%22Katz+SG%22">Katz SG</searchLink>; Department of Pathology, Yale School of Medicine, New Haven, CT, USA.<br /><searchLink fieldCode="AU" term="%22Walensky+LD%22">Walensky LD</searchLink>; Department of Pediatric Oncology and Program in Cancer Chemical Biology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ruppert+SM%22">Ruppert SM</searchLink>; Oncology Biomarker Development, Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Lasater+EA%22">Lasater EA</searchLink>; Department of Translational Oncology, Genentech, South San Francisco, CA, USA.<br /><searchLink fieldCode="AU" term="%22Amann+M%22">Amann M</searchLink>; Roche Innovation Center Zurich, Roche Pharmaceutical Research and Early Development (pRED), Schlieren, Switzerland.<br /><searchLink fieldCode="AU" term="%22Lozano+T%22">Lozano T</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Llopiz+D%22">Llopiz D</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Sarobe+P%22">Sarobe P</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Lasarte+JJ%22">Lasarte JJ</searchLink>; Program of Immunology and Immunotherapy, Center for Applied Medical Research CIMA, University of Navarra, IDISNA, CIBEREHD, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Planell+N%22">Planell N</searchLink>; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Gomez-Cabrero+D%22">Gomez-Cabrero D</searchLink>; Translational Bioinformatics Unit, Navarra-Biomed, Public University of Navarra, IDISNA, Pamplona, Spain.; Biological and Environmental Sciences & Engineering Division, King Abdullah University of Science & Technology, Thuwal, Kingdom of Saudi Arabia.<br /><searchLink fieldCode="AU" term="%22Kudryashova+O%22">Kudryashova O</searchLink>; BostonGene, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Kurilovich+A%22">Kurilovich A</searchLink>; BostonGene, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Revuelta+MV%22">Revuelta MV</searchLink>; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Cerchietti+L%22">Cerchietti L</searchLink>; Department of Medicine, Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Agirre+X%22">Agirre X</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22San+Miguel+J%22">San Miguel J</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Paiva+B%22">Paiva B</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Prosper+F%22">Prosper F</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain.; Department of Hematology, Clinica Universidad de Navarra, CCUN, IDISNA, CIBERONC, Pamplona, Spain.<br /><searchLink fieldCode="AU" term="%22Martinez-Climent+JA%22">Martinez-Climent JA</searchLink>; Division of Hemato-Oncology, Center for Applied Medical Research CIMA, Cancer Center University of Navarra (CCUN), Navarra Institute for Health Research (IDISNA), CIBERONC, Pamplona, Spain. jamcliment@unav.es.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%229502015%22">Nature medicine</searchLink> [Nat Med] 2023 Mar; Vol. 29 (3), pp. 632-645. <i>Date of Electronic Publication: </i>2023 Mar 16.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Company%22">Nature Publishing Company </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>9502015 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1546-170X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210788956%22">10788956 </searchLink><i>NLM ISO Abbreviation: </i>Nat Med <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=36928817
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41591-022-02178-3
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 632
    Titles:
      – TitleFull: Preclinical models for prediction of immunotherapy outcomes and immune evasion mechanisms in genetically heterogeneous multiple myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Larrayoz M
      – PersonEntity:
          Name:
            NameFull: Garcia-Barchino MJ
      – PersonEntity:
          Name:
            NameFull: Celay J
      – PersonEntity:
          Name:
            NameFull: Etxebeste A
      – PersonEntity:
          Name:
            NameFull: Jimenez M
      – PersonEntity:
          Name:
            NameFull: Perez C
      – PersonEntity:
          Name:
            NameFull: Ordoñez R
      – PersonEntity:
          Name:
            NameFull: Cobaleda C
      – PersonEntity:
          Name:
            NameFull: Botta C
      – PersonEntity:
          Name:
            NameFull: Fresquet V
      – PersonEntity:
          Name:
            NameFull: Roa S
      – PersonEntity:
          Name:
            NameFull: Goicoechea I
      – PersonEntity:
          Name:
            NameFull: Maia C
      – PersonEntity:
          Name:
            NameFull: Lasaga M
      – PersonEntity:
          Name:
            NameFull: Chesi M
      – PersonEntity:
          Name:
            NameFull: Bergsagel PL
      – PersonEntity:
          Name:
            NameFull: Larrayoz MJ
      – PersonEntity:
          Name:
            NameFull: Calasanz MJ
      – PersonEntity:
          Name:
            NameFull: Campos-Sanchez E
      – PersonEntity:
          Name:
            NameFull: Martinez-Cano J
      – PersonEntity:
          Name:
            NameFull: Panizo C
      – PersonEntity:
          Name:
            NameFull: Rodriguez-Otero P
      – PersonEntity:
          Name:
            NameFull: Vicent S
      – PersonEntity:
          Name:
            NameFull: Roncador G
      – PersonEntity:
          Name:
            NameFull: Gonzalez P
      – PersonEntity:
          Name:
            NameFull: Takahashi S
      – PersonEntity:
          Name:
            NameFull: Katz SG
      – PersonEntity:
          Name:
            NameFull: Walensky LD
      – PersonEntity:
          Name:
            NameFull: Ruppert SM
      – PersonEntity:
          Name:
            NameFull: Lasater EA
      – PersonEntity:
          Name:
            NameFull: Amann M
      – PersonEntity:
          Name:
            NameFull: Lozano T
      – PersonEntity:
          Name:
            NameFull: Llopiz D
      – PersonEntity:
          Name:
            NameFull: Sarobe P
      – PersonEntity:
          Name:
            NameFull: Lasarte JJ
      – PersonEntity:
          Name:
            NameFull: Planell N
      – PersonEntity:
          Name:
            NameFull: Gomez-Cabrero D
      – PersonEntity:
          Name:
            NameFull: Kudryashova O
      – PersonEntity:
          Name:
            NameFull: Kurilovich A
      – PersonEntity:
          Name:
            NameFull: Revuelta MV
      – PersonEntity:
          Name:
            NameFull: Cerchietti L
      – PersonEntity:
          Name:
            NameFull: Agirre X
      – PersonEntity:
          Name:
            NameFull: San Miguel J
      – PersonEntity:
          Name:
            NameFull: Paiva B
      – PersonEntity:
          Name:
            NameFull: Prosper F
      – PersonEntity:
          Name:
            NameFull: Martinez-Climent JA
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: 2023 Mar
              Type: published
              Y: 2023
          Identifiers:
            – Type: issn-electronic
              Value: 1546-170X
          Numbering:
            – Type: volume
              Value: 29
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Nature medicine
              Type: main
ResultId 1